J
$ Value
$0
Shares
21,228
Price
$0
Filed
Aug 7
Insider
Name
Mayersohn Joel David
Title
—
CIK
0001588395
Roles
Director
Transaction Details
Transaction Date
2025-07-28
Code
J
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
21,228
Footnotes
The shares were acquired through a distribution in kind to limited partners of 10XYZ Holdings, which was the Sponsor of TenX Keane Acquisition ("TenX"), the legacy entity of Citius Oncology, Inc. | The options were granted on December 12, 2024. The options will vest 100% on the one-year anniversary of the grant date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.